~~<i id='273595DD62'><strike id='273595DD62'><tt id='273595DD62'><pre id='273595DD62'></pre></tt></strike></i>~~

Home» focus» comprehensive

comprehensive

author：focus 2025-09-27 14:26:57 Page View：51

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Obesity drug from Roche shows promise in early study
Next article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

explore

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli

Hottest summer in 2,000 years puts focus on extreme heat, health

Inthesummerof2023,peoplesoughtshelterfromarecord-breakingheatwaveinPhoenix.BrandonBell/GettyImagesLa

How one medical school became remarkably diverse

ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

Medical students need to learn the potent medicine of empathy

JoeRaedle/GettyImagesAfewyearsagoatalargeteachinghospitalinTexas,amedicalresidentaskedanursehowtoord